PubMed · 2017

Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity

Djillani A, Pietri M, Moreno S, Heurteaux C, Mazella J, Borsotto M (2017). Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Front Pharmacol.

Front Pharmacol

Source: https://pubmed.ncbi.nlm.nih.gov/28955242/

Last reviewed . By the PeptIQ team.

View original source
XRedditFacebook

Peptides linked in PeptIQ Wiki

    This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.